In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-5 of 5 for your search:
Drug:  blinatumomab
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Active
Age: 35 to 70
Sponsor: NCI
Protocol IDs: NCI-2013-02229, ECOG-E1910, E1910, U10CA021115, U10CA180820, NCT02003222

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 00103311, NCT02013167

3.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00631, COG-AALL1331, AALL1331, U10CA098543, U10CA180886, NCT02101853

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: MT103-205, 2010-024264-18, NCT01471782

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20120216, NCT02000427
New Search